What are the Benefits of Using Spatial Transcriptomics in Cancer?
The primary benefit of spatial transcriptomics in cancer research is the ability to unravel the complex cellular heterogeneity within tumors. This can lead to the identification of rare cell populations that might be responsible for metastasis or resistance to therapy. Furthermore, it can help in the discovery of new biomarkers and therapeutic targets by providing a detailed map of gene expression patterns in different regions of the tumor.
